Thomas Gayner - Markel Group Inc.
Holding/activity history for Novo Nordisk A S (NVO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 2,869,774 | 0.88 | $36.75 | $105,464,196 | SEC | ||
| 2025 Q4 | 2,869,774 | 1.16 | Add 21.16% | 0.20 | $50.88 | $146,014,101 | SEC |
| 2025 Q3 | 2,368,649 | 1.07 | Add 4.87% | 0.05 | $55.49 | $131,436,333 | SEC |
| 2025 Q2 | 2,258,588 | 1.32 | Add 5.05% | 0.06 | $69.02 | $155,887,745 | SEC |
| 2025 Q1 | 2,150,000 | 1.33 | $69.44 | $149,296,000 | SEC | ||
| 2024 Q4 | 2,150,000 | 1.63 | $86.02 | $184,943,001 | SEC | ||
| 2024 Q3 | 2,150,000 | 2.31 | $119.07 | $256,000,501 | SEC | ||
| 2024 Q2 | 2,150,000 | 3.02 | $142.74 | $306,891,000 | SEC | ||
| 2024 Q1 | 2,150,000 | 2.72 | $128.40 | $276,060,000 | SEC | ||
| 2023 Q4 | 2,150,000 | 2.42 | $103.45 | $222,417,500 | SEC | ||
| 2023 Q3 | 2,150,000 | 2.36 | Add 100.00% | 1.18 | $90.94 | $195,521,000 | SEC |
| 2023 Q2 | 1,075,000 | 2.07 | $161.83 | $173,967,250 | SEC | ||
| 2023 Q1 | 1,075,000 | 2.18 | $159.14 | $171,075,501 | SEC | ||
| 2022 Q4 | 1,075,000 | 1.96 | $135.34 | $145,490,501 | SEC | ||
| 2022 Q3 | 1,075,000 | 1.59 | $99.63 | $107,103,000 | SEC | ||
| 2022 Q2 | 1,075,000 | 1.72 | $111.43 | $119,787,000 | SEC | ||
| 2022 Q1 | 1,075,000 | 1.43 | $111.05 | $119,379,000 | SEC | ||
| 2021 Q4 | 1,075,000 | 1.39 | $112.00 | $120,400,000 | SEC | ||
| 2021 Q3 | 1,075,000 | 1.31 | $96.01 | $103,211,000 | SEC | ||
| 2021 Q2 | 1,075,000 | 1.15 | $83.77 | $90,053,000 | SEC | ||
| 2021 Q1 | 1,075,000 | 1.01 | $67.42 | $72,477,000 | SEC | ||
| 2020 Q4 | 1,075,000 | 1.13 | $69.85 | $75,089,000 | SEC | ||
| 2020 Q3 | 1,075,000 | 1.27 | $69.43 | $74,637,000 | SEC | ||
| 2020 Q2 | 1,075,000 | 1.32 | $65.48 | $70,391,000 | SEC | ||
| 2020 Q1 | 1,075,000 | 1.22 | $60.20 | $64,715,000 | SEC | ||
| 2019 Q4 | 1,075,000 | 0.87 | $57.88 | $62,221,000 | SEC | ||
| 2019 Q3 | 1,075,000 | 0.85 | $51.70 | $55,577,000 | SEC | ||
| 2019 Q2 | 1,075,000 | 0.85 | $51.04 | $54,868,000 | SEC | ||
| 2019 Q1 | 1,075,000 | 0.95 | $52.31 | $56,233,000 | SEC | ||
| 2018 Q4 | 1,075,000 | 0.95 | $46.07 | $49,525,000 | SEC | ||
| 2018 Q3 | 1,075,000 | 0.86 | $47.14 | $50,675,000 | SEC | ||
| 2018 Q2 | 1,075,000 | 0.92 | $46.12 | $49,579,000 | SEC | ||
| 2018 Q1 | 1,075,000 | 1.02 | $49.25 | $52,944,000 | SEC | ||
| 2017 Q4 | 1,075,000 | 1.11 | $53.67 | $57,695,000 | SEC | ||
| 2017 Q3 | 1,075,000 | 1.05 | $48.15 | $51,761,000 | SEC | ||
| 2017 Q2 | 1,075,000 | 1.00 | $42.89 | $46,107,000 | SEC | ||
| 2017 Q1 | 1,075,000 | 0.84 | $34.28 | $36,851,000 | SEC | ||
| 2016 Q4 | 1,075,000 | 0.94 | $35.86 | $38,549,000 | SEC | ||
| 2016 Q3 | 1,075,000 | 1.17 | $41.59 | $44,709,000 | SEC | ||
| 2016 Q2 | 1,075,000 | 1.54 | $53.78 | $57,813,000 | SEC | ||
| 2016 Q1 | 1,075,000 | 1.59 | $54.19 | $58,254,000 | SEC | ||
| 2015 Q4 | 1,075,000 | 1.72 | $58.08 | $62,436,000 | SEC | ||
| 2015 Q3 | 1,075,000 | 1.56 | $54.24 | $58,308,000 | SEC | ||
| 2015 Q2 | 1,075,000 | 1.50 | $54.76 | $58,867,000 | SEC | ||
| 2015 Q1 | 1,075,000 | 1.48 | $53.39 | $57,394,000 | SEC | ||
| 2014 Q4 | 1,075,000 | 1.16 | $42.32 | $45,494,000 | SEC | ||
| 2014 Q3 | 1,075,000 | 1.49 | $47.62 | $51,191,000 | SEC | ||
| 2014 Q2 | 1,075,000 | 1.48 | $46.19 | $49,654,000 | SEC | ||
| 2014 Q1 | 1,075,000 | 1.56 | Add 385.99% | 1.24 | $45.65 | $49,074,000 | SEC |
| 2013 Q4 | 221,200 | 1.33 | Reduce 0.23% | <0.01 | $184.76 | $40,869,000 | SEC |
| 2013 Q3 | 221,700 | 1.33 | Reduce 1.51% | 0.02 | $169.22 | $37,516,000 | SEC |
| 2013 Q2 | 225,100 | 1.31 | Reduce 0.57% | <0.01 | $154.97 | $34,884,000 | SEC |
| 2013 Q1 | 226,400 | 1.42 | Reduce 0.40% | <0.01 | $161.50 | $36,564,000 | SEC |
| 2012 Q4 | 227,300 | 1.63 | Reduce 0.35% | <0.01 | $163.21 | $37,098,000 | SEC |
| 2012 Q3 | 228,100 | 1.69 | Reduce 0.35% | <0.01 | $157.81 | $35,996,000 | SEC |
| 2012 Q2 | 228,900 | 1.66 | Add 0.84% | 0.01 | $145.34 | $33,268,000 | SEC |
| 2012 Q1 | 227,000 | 1.56 | Reduce 0.96% | 0.01 | $138.71 | $31,487,000 | SEC |
| 2011 Q4 | 229,200 | 1.52 | Reduce 0.11% | <0.01 | $115.26 | $26,418,000 | SEC |
| 2011 Q3 | 229,450 | 1.48 | $99.52 | $22,835,000 | SEC | ||
| 2011 Q2 | 229,450 | 1.62 | Reduce 0.09% | <0.01 | $125.28 | $28,745,000 | SEC |
| 2011 Q1 | 229,650 | 1.68 | Reduce 0.43% | <0.01 | $125.23 | $28,759,000 | SEC |
| 2010 Q4 | 230,650 | 1.54 | Reduce 0.09% | <0.01 | $112.57 | $25,964,000 | SEC |
| 2010 Q3 | 230,850 | 1.48 | Reduce 0.28% | <0.01 | $98.44 | $22,725,000 | SEC |
| 2010 Q2 | 231,500 | 1.35 | $81.02 | $18,756,000 | SEC | ||
| 2010 Q1 | 231,500 | 1.20 | Add 39.04% | 0.34 | $77.12 | $17,853,000 | SEC |
| 2009 Q4 | 166,500 | 0.77 | Buy | 0.77 | $63.85 | $10,631,000 | SEC |